NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.26
-0.59 (-1.65%)
At close: Dec 5, 2025, 4:00 PM EST
35.00
-0.26 (-0.74%)
After-hours: Dec 5, 2025, 6:50 PM EST
NAMS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 538.41 | 771.74 | 340.45 | 467.73 | 60.38 | 9.62 |
| Short-Term Investments | 164.54 | 62.45 | - | - | - | - |
| Cash & Short-Term Investments | 702.95 | 834.19 | 340.45 | 467.73 | 60.38 | 9.62 |
| Cash Growth | 66.29% | 145.03% | -27.21% | 674.64% | 527.92% | - |
| Other Receivables | 20.25 | 21.31 | 1.88 | 2.07 | 4.88 | - |
| Receivables | 20.25 | 21.31 | 1.88 | 2.07 | 4.88 | - |
| Prepaid Expenses | 7.83 | 7.92 | 4.46 | 8.18 | 1.7 | 1.66 |
| Total Current Assets | 732.33 | 863.41 | 346.79 | 477.98 | 66.96 | 11.28 |
| Property, Plant & Equipment | 0.57 | 0.67 | 0.1 | 0.15 | 0.22 | 0.01 |
| Other Intangible Assets | 0.44 | 0.53 | 0.17 | 0.21 | - | - |
| Other Long-Term Assets | - | - | 0.04 | 0.16 | - | - |
| Total Assets | 786.43 | 864.62 | 347.1 | 478.5 | 67.99 | 11.29 |
| Accounts Payable | 3.63 | 4.74 | 16.92 | 11.85 | 7.07 | 0.48 |
| Accrued Expenses | 10.1 | 13.61 | 11.4 | 6.12 | 4.1 | 0.93 |
| Short-Term Debt | - | - | - | - | - | 14.25 |
| Current Portion of Leases | 0.18 | 0.25 | 0.06 | 0.07 | 0.06 | - |
| Current Unearned Revenue | - | 6.01 | 8.94 | 13.87 | - | - |
| Other Current Liabilities | 44.36 | 82.31 | 12.57 | 4.15 | - | - |
| Total Current Liabilities | 58.27 | 106.92 | 49.9 | 36.06 | 11.24 | 15.67 |
| Long-Term Leases | 0.09 | 0.2 | - | 0.06 | 0.13 | - |
| Long-Term Unearned Revenue | - | - | 1.02 | 4.79 | - | - |
| Other Long-Term Liabilities | - | - | 7.79 | 7.52 | - | - |
| Total Liabilities | 58.36 | 107.12 | 58.7 | 48.43 | 11.36 | 15.67 |
| Common Stock | 14.11 | 13.44 | 10.17 | 10.06 | 0.13 | 0.06 |
| Additional Paid-In Capital | 1,397 | 1,298 | 590.77 | 555.63 | 95.26 | 3 |
| Retained Earnings | -687.47 | -558.57 | -316.97 | -140.04 | -39.44 | -7.43 |
| Comprehensive Income & Other | 4.64 | 4.47 | 4.42 | 4.42 | 0.67 | - |
| Shareholders' Equity | 728.07 | 757.5 | 288.39 | 430.07 | 56.63 | -4.38 |
| Total Liabilities & Equity | 786.43 | 864.62 | 347.1 | 478.5 | 67.99 | 11.29 |
| Total Debt | 0.27 | 0.45 | 0.06 | 0.13 | 0.19 | 14.25 |
| Net Cash (Debt) | 755.77 | 833.74 | 340.39 | 467.6 | 60.19 | -4.63 |
| Net Cash Growth | 79.00% | 144.94% | -27.21% | 676.83% | - | - |
| Net Cash Per Share | 6.67 | 8.84 | 4.14 | 24.65 | 5.48 | -0.93 |
| Filing Date Shares Outstanding | 113.39 | 109.82 | 89.27 | 81.77 | 11.33 | 5 |
| Total Common Shares Outstanding | 113.17 | 108.06 | 82.47 | 81.56 | 11.33 | 5 |
| Working Capital | 674.06 | 756.5 | 296.89 | 441.92 | 55.72 | -4.39 |
| Book Value Per Share | 6.43 | 7.01 | 3.50 | 5.27 | 5.00 | -0.88 |
| Tangible Book Value | 727.63 | 756.97 | 288.22 | 429.86 | 56.63 | -4.38 |
| Tangible Book Value Per Share | 6.43 | 7.00 | 3.49 | 5.27 | 5.00 | -0.88 |
| Machinery | - | - | - | - | 0.04 | 0.02 |
Source: S&P Capital IQ. Standard template. Financial Sources.